ALX/FPR2 Activation by Stereoisomers of D1 Resolvins Elucidating with Molecular Dynamics Simulation-Reference-Cited by-同舟云学术

ALX/FPR2 Activation by Stereoisomers of D1 Resolvins Elucidating with Molecular Dynamics Simulation

Published:2023-07-10 Issue:29 Volume:127 Page:6479-6486
ISSN:1520-6106
Container-title:The Journal of Physical Chemistry B
language:en
Short-container-title:J. Phys. Chem. B

Author:

Nunes Vinicius S.¹²^ORCID,Abrahão Odonírio²,Rogério Alexandre P.³,Serhan Charles N.⁴^ORCID

Affiliation:

1. Laboratório Nacional de Computação Científica, Petrópolis, Rio de Janeiro, 25651-076, Brasil

2. Laboratório de Química Computacional Medicinal, Universidade Federal do Triângulo Mineiro, Uberaba, Minas Gerais, 38025-180, Brasil

3. Laboratório de Imunofarmacologia Experimental, Universidade Federal do Triângulo Mineiro, Uberaba, Minas Gerais, 38025-180, Brasil

4. Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts 02115, United States

Funder

Minist?rio da Ci?ncia, Tecnologia e Inova??o

Conselho Nacional de Desenvolvimento Cient?fico e Tecnol?gico

National Institute of General Medical Sciences

Laborat?rio Nacional de Computa??o Cient?fica

Publisher

American Chemical Society (ACS)

Subject

Materials Chemistry,Surfaces, Coatings and Films,Physical and Theoretical Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jpcb.3c01787

Reference55 articles.

1. PROSTAGLANDINS AND LEUKOTRIENES

2. Identification of Chemotype Agonists for Human Resolvin D1 Receptor DRV1 with Pro-Resolving Functions

3. Pro-resolving lipid mediators are leads for resolution physiology

4. Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators

5. Resolvin D1 and Its Aspirin-triggered 17R Epimer

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research progress in the mechanisms and functions of specialized pro-resolving mediators in neurological diseases;Prostaglandins & Other Lipid Mediators;2024-12